Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV study

Damgacioglu, 2022, Oropharyngeal cancer incidence and mortality trends in all 50 states in the US, 2001–2017, JAMA Otolaryngol Neck Surg, 148, 155, 10.1001/jamaoto.2021.3567 Jemal, 2013, Annual Report to the Nation on the Status of Cancer, 1975–2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels, J Natl Cancer Inst, 105, 175, 10.1093/jnci/djs491 Ang, 2010, Human papillomavirus and survival of patients with oropharyngeal cancer, N Engl J Med, 363, 24, 10.1056/NEJMoa0912217 Truong Lam, 2016, Challenges in establishing the diagnosis of human papillomavirus-related oropharyngeal carcinoma, Laryngoscope, 126, 2270, 10.1002/lary.25985 Davis, 2020, From presumed benign neck masses to delayed recognition of human papillomavirus–positive oropharyngeal cancer, Laryngoscope, 130, 392, 10.1002/lary.27946 Karp, 2021, Barriers to obtaining a timely diagnosis in human papillomavirus-associated oropharynx cancer, Otolaryngol Neck Surg, 165, 300, 10.1177/0194599820982662 Berger, 2018, Assessment of human papillomavirus awareness in association with head and neck cancer at a screening event, Laryngoscope, 128, 386, 10.1002/lary.26739 Jackowska, 2015, The knowledge of the role of papillomavirus - Related head and neck pathologies among general practitioners, otolaryngologists and trainees. A survey-based study, PLoS ONE, 10, 1, 10.1371/journal.pone.0141003 Lechner, 2018, A cross-sectional survey of awareness of human papillomavirus-associated oropharyngeal cancers among general practitioners in the UK, BMJ Open, 8, 10.1136/bmjopen-2018-023339 Bannister, 2014, Is oropharyngeal cancer being misdiagnosed as acute tonsillitis?, Br J Gen Pract, 64, e742, 10.3399/bjgp14X682537 Gilde, 2018, The diagnostic pathway of oropharyngeal squamous cell carcinoma in a large U.S. healthcare system, Laryngoscope, 128, 1867, 10.1002/lary.27038 Rollo, 2018, Cytology and direct human papillomavirus testing on fine needle aspirates from cervical lymph node metastases of patients with oropharyngeal squamous cell carcinoma or occult primary, Cytopathol Off J Br Soc Clin Cytol., 29, 449 Morse, 2022, Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma, Oral Oncol, 134, 10.1016/j.oraloncology.2022.106131 Yang, 2019, HPV testing through p16 immunocytochemistry in neck-mass FNA and its correlation with tissue samples, Cancer Cytopathol, 127, 458, 10.1002/cncy.22156 Aulakh, 2022, The Promise of Circulating Tumor DNA in Head and Neck Cancer, Cancers, 14, 2968, 10.3390/cancers14122968 Krasniqi, 2021, Circulating HPV DNA in the management of oropharyngeal and cervical cancers: current knowledge and future perspectives, J Clin Med, 10, 1525, 10.3390/jcm10071525 Haring, 2022, The future of circulating tumor DNA as a biomarker in HPV related oropharyngeal squamous cell carcinoma, Oral Oncol, 126, 10.1016/j.oraloncology.2022.105776 Chera, 2019, Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer, Clin Cancer Res Off J Am Assoc Cancer Res, 25, 4682, 10.1158/1078-0432.CCR-19-0211 Cao, 2012, Quantitation of human papillomavirus DNA in plasma of oropharyngeal carcinoma patients, Int J Radiat Oncol Biol Phys, 82, e351, 10.1016/j.ijrobp.2011.05.061 Gunning, 2023, Analytical Validation of NavDx, a cfDNA-Based Fragmentomic Profiling Assay for HPV-Driven Cancers, Diagnostics, 13, 725, 10.3390/diagnostics13040725 Rettig, 2022, Association of pretreatment circulating tumor tissue–modified viral HPV DNA with clinicopathologic factors in HPV-positive oropharyngeal cancer, JAMA Otolaryngol Neck Surg, 148, 1120, 10.1001/jamaoto.2022.3282 Rettig, 2022, Detection of circulating tumor human papillomavirus DNA before diagnosis of HPV-positive head and neck cancer, Int J Cancer, 151, 1081, 10.1002/ijc.33996 D’Souza, 2019, Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer, Cancer Prev Res Phila, 12, 689, 10.1158/1940-6207.CAPR-19-0185 Robbins, 2022, Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 serology test and potential implications for screening: results from the human papillomavirus cancer cohort consortium, J Clin Oncol, 40, 3613, 10.1200/JCO.21.01785 Kreimer, 2018, Screening for human papillomavirus-driven oropharyngeal cancer: Considerations for feasibility and strategies for research, Cancer, 124, 1859, 10.1002/cncr.31256 Siravegna, 2022, Cell-free HPV DNA provides an accurate and rapid diagnosis of HPV-associated head and neck cancer, Clin. Cancer Res., 28, 719, 10.1158/1078-0432.CCR-21-3151 Berger, 2022, Detection of occult recurrence using circulating tumor tissue modified viral HPV DNA among patients treated for HPV-driven oropharyngeal carcinoma, Clin. Cancer Res., 28, 4292, 10.1158/1078-0432.CCR-22-0562 Harris, 2009, Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support, J Biomed Inform, 42, 377, 10.1016/j.jbi.2008.08.010 Harris, 2019, The REDCap consortium: Building an international community of software platform partners, J Biomed Inform, 95, 10.1016/j.jbi.2019.103208 D’Souza, 2020, Long-term Persistence of Oral HPV Over 7 Years of Follow-up, JNCI Cancer Spectr, 4, 10.1093/jncics/pkaa047 Gerndt, 2021, Evaluating a clinically validated circulating tumor HPV DNA assay in saliva as a proximal biomarker in HPV+ oropharyngeal squamous cell carcinoma, J Clin Oncol, 39, 10.1200/JCO.2021.39.15_suppl.6063 Connal, 2023, Liquid biopsies: the future of cancer early detection, J Transl Med, 21, 118, 10.1186/s12967-023-03960-8 Naegele, 2023, Detection and Monitoring of Circulating Tumor HPV DNA in HPV-Associated Sinonasal and Nasopharyngeal Cancers. JAMA Otolaryngol–, Head Neck Surg, 149, 179 Garda, 2020, Pre-Treatment Circulating Tumor Human Papillomavirus (HPV) DNA and Recurrence Risk in HPV Associated Malignancy: Oropharyngeal, Anal Canal, and Cervical Cancer, Int J Radiat Oncol Biol Phys, 108, S6, 10.1016/j.ijrobp.2020.07.2078